Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19.

Cai, Hong; Yan, Jiayi; Wang, Jieying; Che, Xiajing; Mou, Shan

Cai, Hong; Yan, Jiayi; Wang, Jieying; Che, Xiajing; Mou, Shan.

Cai H; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Yan J; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Wang J; Clinical Research Unit, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Che X; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Electronic address: Chexj@126.com.
Mou S; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Electronic address: shan_mou@shsmu.edu.cn.

J Infect ; 85(6): 702-769, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2061549

Subject(s)

Acute Kidney Injury; COVID-19; Humans; Acute Kidney Injury/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / COVID-19 Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.10.002

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google